Credit Suisse’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-721,699
| Closed | -$3.72M | – | 3575 |
|
|
2019
Q2 | $3.72M | Buy |
721,699
+703,133
| +3,787% | +$3.63M | ﹤0.01% | 1530 |
|
|
2019
Q1 | $66K | Sell |
18,566
-221,636
| -92% | -$788K | ﹤0.01% | 3292 |
|
|
2018
Q4 | $1.47M | Buy |
+240,202
| New | +$1.47M | ﹤0.01% | 2017 |
|
|
2018
Q3 | – | Sell |
-14,527
| Closed | -$62K | – | 3523 |
|
|
2018
Q2 | $62K | Sell |
14,527
-17,378
| -54% | -$74.2K | ﹤0.01% | 3420 |
|
|
2018
Q1 | $140K | Buy |
31,905
+14,621
| +85% | +$64.2K | ﹤0.01% | 3330 |
|
|
2017
Q4 | $91K | Sell |
17,284
-10,995
| -39% | -$57.9K | ﹤0.01% | 3348 |
|
|
2017
Q3 | $173K | Buy |
28,279
+14,751
| +109% | +$90.2K | ﹤0.01% | 3485 |
|
|
2017
Q2 | $98K | Buy |
13,528
+1,495
| +12% | +$10.8K | ﹤0.01% | 3331 |
|
|
2017
Q1 | $63K | Sell |
12,033
-13,277
| -52% | -$69.5K | ﹤0.01% | 3354 |
|
|
2016
Q4 | $182K | Sell |
25,310
-42,689
| -63% | -$307K | ﹤0.01% | 3479 |
|
|
2016
Q3 | $636K | Buy |
67,999
+41,244
| +154% | +$386K | ﹤0.01% | 2960 |
|
|
2016
Q2 | $169K | Sell |
26,755
-305
| -1% | -$1.93K | ﹤0.01% | 3622 |
|
|
2016
Q1 | $149K | Sell |
27,060
-7,710
| -22% | -$42.5K | ﹤0.01% | 3457 |
|
|
2015
Q4 | $195K | Buy |
34,770
+18,962
| +120% | +$106K | ﹤0.01% | 3673 |
|
|
2015
Q3 | $133K | Sell |
15,808
-59,869
| -79% | -$504K | ﹤0.01% | 3834 |
|
|
2015
Q2 | $1.14M | Buy |
75,677
+3,747
| +5% | +$56.6K | ﹤0.01% | 2804 |
|
|
2015
Q1 | $1.15M | Buy |
71,930
+16,579
| +30% | +$266K | ﹤0.01% | 2612 |
|
|
2014
Q4 | $987K | Buy |
55,351
+30,210
| +120% | +$539K | ﹤0.01% | 2809 |
|
|
2014
Q3 | $253K | Sell |
25,141
-2,605
| -9% | -$26.2K | ﹤0.01% | 3626 |
|
|
2014
Q2 | $433K | Sell |
27,746
-82,194
| -75% | -$1.28M | ﹤0.01% | 3496 |
|
|
2014
Q1 | $2.04M | Buy |
+109,940
| New | +$2.04M | ﹤0.01% | 2190 |
|